[fcb5af]: / literature / by_gene_clean / NFKB1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35089437 10.1007/s00018-022-04139-y 2022 A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. NFKB1
2 36009586 10.3390/biomedicines10082038 2022 Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma. NFKB1
3 30887112 10.1007/s00109-019-01777-x 2019 Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α. NFKB1
4 29593668 10.3389/fmicb.2018.00380 2018 Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins. NFKB1
5 27840321 10.1016/j.freeradbiomed.2016.11.010 2017 Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2. NFKB1
6 28281555 10.1038/modpathol.2017.5 2017 NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53. NFKB1
7 28368397 10.1038/onc.2017.90 2017 Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. NFKB1
8 28672935 10.3892/etm.2017.4464 2017 Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer. NFKB1
9 26767426 10.1016/j.jid.2015.12.027 2016 MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation. NFKB1
10 26776161 10.1038/onc.2015.493 2016 Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. NFKB1
11 26792751 10.1128/JVI.03000-15 2016 The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein. NFKB1
12 27262792 10.1016/j.semcancer.2016.05.002 2016 Mechanisms of NF-κB deregulation in lymphoid malignancies. NFKB1
13 27452667 10.1016/j.semcancer.2016.07.003 2016 MALT lymphoma: A paradigm of NF-κB dysregulation. NFKB1
14 25960206 10.1002/gcc.22253 2015 NFkB is activated by multiple mechanisms in hairy cell leukemia. NFKB1
15 25996250 10.1111/febs.13325 2015 MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression. NFKB1
16 26487345 10.1038/srep15215 2015 Transcription factor and miRNA co-regulatory network reveals shared and specific regulators in the development of B cell and T cell. NFKB1
17 26668357 10.1073/pnas.1507459112 2015 Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation. NFKB1
18 24200242 10.1089/scd.2013.0270 2014 Resistance of hematopoietic progenitors to Fas-mediated apoptosis is actively sustained by NFκB with a characteristic transcriptional signature. NFKB1
19 24704296 10.1016/j.canlet.2014.03.030 2014 The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma. NFKB1
20 19897484 10.1074/jbc.M109.050815 2010 B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation. NFKB1
21 19412164 10.1038/nature07968 2009 Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. NFKB1
22 19573080 10.1111/j.1365-2141.2009.07790.x 2009 Common genetic variants in candidate genes and risk of familial lymphoid malignancies. NFKB1
23 19709433 10.1186/1476-4598-8-67 2009 STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. NFKB1
24 19773279 10.1136/oem.2008.044024 2009 Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. NFKB1
25 18252714 10.1074/jbc.M708833200 2008 Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. NFKB1
26 18636124 10.1371/journal.pone.0002816 2008 Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. NFKB1
27 17356384 10.1097/01.jnen.0000248553.45456.96 2007 Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression. NFKB1
28 17502353 10.1128/MCB.01645-06 2007 Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation. NFKB1
29 15231650 10.1158/0008-5472.CAN-03-3885 2004 High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. NFKB1
30 15514680 10.1038/sj.embor.7400280 2004 Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds. NFKB1
31 12032828 10.1038/sj.onc.1205483 2002 NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. NFKB1